FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

838469001: Trastuzumab deruxtecan (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3897070019 Trastuzumab deruxtecan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3897071015 Trastuzumab deruxtecan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab deruxtecan Is a Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Trastuzumab deruxtecan This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Trastuzumab deruxtecan Is a Enzyme inhibitor protein true Inferred relationship Some
Trastuzumab deruxtecan This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Trastuzumab deruxtecan Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some
Trastuzumab deruxtecan This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Trastuzumab (substance) false Inferred relationship Some
Trastuzumab deruxtecan Is a Antineoplastic agent (substance) false Inferred relationship Some
Trastuzumab deruxtecan Is a Immunosuppressant (substance) true Inferred relationship Some
Trastuzumab deruxtecan Is a Monoclonal antibody true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing trastuzumab deruxtecan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trastuzumab deruxtecan Inferred relationship Some 1
Product containing only trastuzumab deruxtecan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trastuzumab deruxtecan Inferred relationship Some 1
Product containing trastuzumab deruxtecan in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trastuzumab deruxtecan Inferred relationship Some 1
Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trastuzumab deruxtecan Inferred relationship Some 1
Trastuzumab deruxtecan 100 mg powder for solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Trastuzumab deruxtecan Inferred relationship Some 1
Trastuzumab deruxtecan 100 mg powder for solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Trastuzumab deruxtecan Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start